Phoebe joined KCL in late 2022 as a Research Assistant for the LonDownS project and Horizon 21 study, which focus on biomarkers and risk factors for the early development of Alzheimer’s in people with Down Syndrome. Prior to this, Phoebe obtained a BA in Behavioural Neuroscience from Connecticut College and an MSc in Translational Neuroscience from Imperial College London.

Phoebe previously worked as a Research Assistant for the Centre for Perinatal Neuroscience at Imperial for 3 years. Her work focused on using magnetic resonance imaging and spectroscopy biomarkers to prognosticate cognitive outcomes in newborns with hypoxic-ischemic encephalopathy.

Research Interests

• Neuroimaging
• Neurodevelopment
• Neurodegeneration

Research Groups & Projects

• Group: London Down Syndrome (LonDownS) Consortium
• Projects: 
  -  LonDownS
  -  Horizon 21
  -  GO-DS21

Expertise and Public Engagement

Phoebe Ivain has been a volunteer biology tutor for the Access Project since 2021. The Access Project aims to support students from disadvantaged backgrounds to access top universities through tuition and in-school mentoring.

Publications

• Montaldo P*, Ivain P*, Lally P, Bassett P, Pant S, Oliveira V, Mendoza J, Morales M, Swamy R, Shankaran S, Thayyil S. White matter injury after neonatal encephalopathy is associated with thalamic metabolite perturbations. EBioMedicine. 2020 Feb 1; 52:102663. *Joint first
  
• Thayyil S, Pant S, Montaldo P, Shukla D, Oliveira V, Ivain P, Bassett P, Swamy R, Mendoza J, Moreno-Morales M, Lally PJ. Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka, and Bangladesh. The Lancet Global Health. 2021 Sep 1;9(9):e1273-85.
• Ivain P, Montaldo P, Khan A, Elagovan R, Burgod C, Morales MM, Pant S, Thayyil S. Erythropoietin monotherapy for neuroprotection after neonatal encephalopathy in low-to-middle income countries: a systematic review and meta-analysis. Journal of Perinatology. 2021 Sep;41(9):2134-40.